Inhalation of nitric oxide inhibits ADP-induced platelet aggregation and α-granule release

Platelets

Volumn 10, Issue 6, 1999, Pages 382-390

  Hagberg, Inger Anne ^a   Sølvik, Una Ørvim ^b   Opdahl, Helge ^a   Roald, Helge Einar ^b   Lyberg, Torstein ^a  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; ALPHA2 INTEGRIN; ANTIGEN; CD42A ANTIGEN; CD45 ANTIGEN; CD61 ANTIGEN; FIBRIN ANTIBODY; FLUOROCHROME; LIPOCORTIN 5; NITRIC OXIDE; PADGEM PROTEIN; THROMBIN RECEPTOR ACTIVATING PEPTIDE; UNCLASSIFIED DRUG;

ADULT; ARTERY BLOOD FLOW; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN EXPERIMENT; INHALATION; MALE; MODEL; NORMAL HUMAN; PRIORITY JOURNAL; STAIN; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE AGGREGATION INHIBITION; THROMBUS;

THROMBUS;

EID: 0033404354     PISSN: 09537104     EISSN: None     Source Type: Journal    
DOI: 10.1080/09537109975852     Document Type: Article

References (42)

1. 1. Frostell C G, Blomqvist H, Hedenstierna G, Lundberg J, Zapol W M. Inhaled nitric oxide selectively reverses human hypoxic pulmonary vasoconstriction without causing systemic vasodilation. Anesthesiology 1993; 78: 427-35.
2. 2. Chollet-Martin S, Gatecel C, Kermarrec N, Gougerot-Pocidalo M A, Payen D M. Alveolar neutrophil functions and cytokine levels in patients with the adult respiratory distress syndrome during nitric oxide inhalation. Am J Respir Crit Care Med 1996; 153: 985-90.
3. 3. Nong Z, Hoylaerts M, Van Pelt N, Collen D, Janssens S. Nitric oxide inhalation inhibits platelet aggregation and platelet-mediated pulmonary thrombosis in rats. Circ Res 1997; 81: 865-9.
4. 4. Radomski M W, Palmer R M, Moncada S. Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet 1987; 2: 1057-8.
5. 5. Lopez-Farre A, Caramelo C, Esteban A, Alberola M L, Millas I, Monton M, Casado S. Effects of aspirin on platelet-neutrophil interactions. Role of nitric oxide and endothelin-1. Circulation 1995; 91: 2080-8.
6. 6. Freedman J E, Loscalzo J, Barnard M R, Alpert C, Keaney J F, Michelson A D. Nitric oxide released from activated platelets inhibits platelet recruitment. J Clin Invest 1997; 100: 350-6.
7. 7. Moro M A, Russel R J, Cellek S, Lizasoain I, Su Y, Darley-Usmar V M, Radomski M W, Moncada S. cGMP mediates the vascular and platelet actions of nitric oxide: confirmation using an inhibitor of the soluble guanylyl cyclase. Proc Natl Acad Sci USA 1996; 93: 1480-5.
8. 8. Langford E J, Wainwright R J, Martin J F. Platelet activation in acute myocardial infarction and unstable angina is inhibited by nitric oxide donors. Arterioscler Thromb Vasc Biol 1996; 16: 51-5.
9. 9. Mellion B T, Ignarro L J, Ohlstein E H, Pontecorvo E G, Hyman A L, Kadowitz P J. Evidence for the inhibitory role of guanosine 3′,5′-monophosphate in ADP-induced human platelet aggregation in the presence of nitric oxide and related vasodilators. Blood 1981; 57: 946-55.
10. 10. Harris S N, Rinder C S, Rinder H M, Tracey J B, Smith B R, Hines R. Nitroprusside inhibition of platelet function is transient and reversible by catecholamine priming. Anesthesiology 1995; 83: 1145-52.
11. 11. Hogman M, Frostell C, Arnberg H, Sandhagen B, Hedenstierna G. Prolonged bleeding time during nitric oxide inhalation in the rabbit. Acta Physiol Scand 1994; 151: 125-9.
12. 12. Kinlough-Rathbone R L, Perry D W, Guccione M A, Rand M L, Packham M A. Degranulation of human platelets by the thrombin receptor peptide SFLLRN: Comparison with degranulation by thrombin. Thromb Haemost 1993; 70: 1019-23.
13. 13. Sakariassen K S, Kuhn H, Muggli R, Baumgartner H R. Growth and stability of thrombi in flowing citrated blood: assessment of platelet-surface interactions with computer-assisted morphometry. Thromb Haemost 1988; 60: 392-8.
14. 14. Sakariassen K S, Weiss H J, Baumgartner H R. Upstream thrombus growth impairs downstream thrombogenesis in non-anticoagulated blood: effect of procoagulant artery subendothelium and non-procoagulant collagen. Thromb Haemost 1991; 65: 596-600.
15. 15. Roald H E, Orvim U, Bakken I J, Barstad R M, Kierulf P, Sakariassen K S. Modulation of thrombotic responses in moderately stenosed arteries by cigarette smoking and aspirin ingestion. Arterioscler Thromb 1994; 14: 617-21.
16. 16. Sakariassen K S, Aarts P A, de Groot P G, Houdijk W P, Sixma J J. A perfusion chamber developed to investigate platelet interaction in flowing blood with human vessel wall cells, their extracellular matrix, and purified components. J Lab Clin Med 1983; 102: 522-35.
17. 17. Hagberg I A, Roald H E, Lyberg T. Adhesion of leukocytes to growing arterial thrombi. Thromb Haemost 1998; 80: 852-8.
18. 18. Misko T P, Schilling R J, Salvemini D, Moore W M, Currie M G. A fluorometric assay for the measurement of nitrite in biological samples. Anal Biochem 1993; 214: 11-6.
19. 19. Hegesh E, Shiloah J. Blood nitrates and infantile methemoglobinemia. Clin Chim Acta 1982; 125: 107-15.
20. 20. Adrie C, Bloch K D, Moreno P R, Hurford W E, Guerrero J L, Holt R, Zapol W M, Gold H K, Semigran M J. Inhaled nitric oxide increases coronary artery patency after thrombolysis. Circulation 1996; 94: 1919-26.
21. 21. Gries A, Bottiger B W, Dorsam J, Bauer H, Weimann J, Bode C, Martin E, Motsch J. Inhaled nitric oxide inhibits platelet aggregation after pulmonary embolism in pigs. Anesthesiology 1997; 86: 387-93.
22. 22. Samama C M, Diaby M, Fellahi J L, Mdhafar A, Eyraud D, Arock M, Guillosson J J, Coriat P, Rouby J J. Inhibition of platelet aggregation by inhaled nitric oxide in patients with acute respiratory distress syndrome. Anesthesiology 1995; 83: 56-65.
23. 23. Hogman M, Frostell C, Arnberg H, Hedenstierna G. Bleeding time prolongation and NO inhalation. Lancet 1993; 341: 1664-5.
24. 24. Albert J, Wallen N H, Broijersen A, Frostell C, Hjemdahl P. Effects of inhaled nitric oxide compared with aspirin on platelet function in vivo in healthy subjects. Clin Sci (Colch) 1996; 91: 225-31.
25. 25. Young J D, Sear J W, Valvini E M. Kinetics of methaemoglobin and serum nitrogen oxide production during inhalation of nitric oxide in volunteers. Br J Anaesth 1996; 76: 652-6.
26. 26. Loscalzo J, Welch G. Nitric oxide and its role in the cardiovascular system. Prog Cardiovasc Dis 1995; 38: 87-104.
27. 27. Aoki H, Inoue M, Mizobe T, Harada M, Imai H, Kobayashi A. Platelet function is inhibited by nitric oxide liberation during nitroglycerin-induced hypotension anaesthesia. Br J Anaesth 1997; 79: 476-81.
28. 28. Mendelsohn M E, O'Neill S, George D, Loscalzo J. Inhibition of fibrinogen binding to human platelets by S-nitroso-N-acetylcysteine. J Biol Chem 1990; 265: 19028-34.
29. 29. Daniel J L, Dangelmaier C, Jin J, Ashby B, Smith J B, Kunapuli S P. Molecular basis for ADP-induced platelet activation. I. Evidence for three distinct ADP receptors on human platelets. J Biol Chem 1998; 273: 2024-9.
30. 30. Jin J, Kunapuli S P. Coactivation of two different G protein-coupled receptors is essential for ADP-induced platelet aggregation. Proc Natl Acad Sci USA 1998; 95: 8070-4.
31. 31. Savi P, Nurden P, Nurden A T, Levy Toledano S, Herbert J M. Clopidogrel: A review of its mechanism of action. Platelets 1998; 9: 251-5.
32. 32. Murad F. The role of nitric oxide in modulating guanylyl cyclase. Neurotransmissions 1994; x: 1-4.
33. 33. Jensen B O, Holmsen H. Nitric oxide (NO)-platelet interactions: inhibition is independent of the prostanoid and ADP pathways. Platelets 1994; 5: 83-90.
34. 34. Murohara T, Parkinson S J, Waldman S A, Lefer A M. Inhibition of nitric oxide biosynthesis promotes P-selectin expression in platelets. Role of protein kinase C. Arterioscler Thromb Vasc Biol 1995; 15: 2068-75.
35. 35. Michelson A D, Benoit S E, Furman M I, Breckwoldt W L, Rohrer M J, Barnard M R, Loscalzo J. Effects of nitric oxide/EDRF on platelet surface glycoproteins. Am J Physiol 1996; 270 (part 2): H1640-8.
36. 36. Roald H E, Barstad R M, Kierulf P, Skjorten F, Dickinson J P, Kieffer G, Sakariassen K S. Clopidogrel-a platelet inhibitor which inhibits thrombogenesis in non-anticoagulated human blood independently of the blood flow conditions. Thromb Haemost 1994; 71: 655-62.
37. 37. Rinder H M, Bonan J L, Rinder C S, Ault K A, Smith B R. Dynamics of leukocyte-platelet adhesion in whole blood. Blood 1991; 78: 1730-7.
38. 38. Evangelista V, Manarini S, Rotondo S, Martelli N, Polischuk R, McGregor J L, de Gaetano G, Cerletti C. Plalelet/polymorphonuclear leukocyte interaction in dynamic conditions: evidence of adhesion cascade and cross talk between P-selectin and the beta 2 integrin CDIIb/CD18. Blood 1996; 88: 4183-94.
39. 39. Yeo E L, Sheppard J A, Feuerstein I A. Role of P-selectin and leukocyte activation in polymorphonuclear cell adhesion to surface adherent activated platelets under physiologic shear conditions (an injury vessel wall model). Blood 1994; 83: 2498-507.
40. 40. Ruf A, Patscheke H. Platelet-induced neutrophil activation: platelet-expressed fibrinogen induces the oxidative burst in neutrophils by an interaction with CDIIC/CD18. Br J Haematol 1995; 90: 791-6.
41. 41. Neumann F J, Marx N, Gawaz M, Brand K, Ott I, Rokitta C, Sticherling C, Meinl C, May A, Schomig A. Induction of cytokine expression in leukocytes by binding of thrombin-stimulated platelets. Circulation 1997; 95: 2387-94.
42. 42. Osterud B. Cellular interactions in tissue factor expression by blood monocytes. Blood Coag Fibrinol 1995; 6: S20-5.